In contrast to VEGF inhibition, the clinical relevance of ANG2 inhibition in patients with retinal disease, such that levels are suppressed to below physiologically normal levels, has yet to be demonstrated. The gene discussed is VEGFA; the disease is Abnormal retinal morphology.